Biliary Atresia: Clinical Trials

1 trial for Biliary Atresia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Biliary Atresia: new trials by email Literature Review of Biliary Atresia trials Research Report on Biliary Atresia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
OCA, Matching Placebo - Biliary Atresia
Phase 2 / Phase 3TerminatedIntercept Pharmaceuticals282024-09-022026-07-07

Broader conditions

Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Abnormalities (1)  ·  Digestive System Diseases (1)

Sponsors

Intercept Pharmaceuticals (1)

Countries

Australia (1)  ·  Canada (1)  ·  China (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  Malaysia (1)  ·  New Zealand (1)  ·  Singapore (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Lynda Szczech, MD (1)